Comply or face action, US FDA tells Indian drugmakers

Comments 0
SummaryFDA also warned of “appropriate action” against the companies failing to implement “good manufacturing practices”.

Indian drugmakers find themselves on wrong side of American rules, the US health regulator FDA says they are finding contaminants like filth, pesticides and insect parts in drugs manufactured here, but similar problems exist in many other countries too.

FDA also warned of “appropriate action” against the companies failing to implement “good manufacturing practices”. The watchdog said many Indian drugmakers are well-compliant with the rules in the US, to whom India is the second largest drug exporter, while it is ready to provide guidance to others that “present problems and challenges”.

Ads by Google

More from Economy

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...